Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Hologic, Inc.
Hologic’s recent buy-outs put it in a strengthened growth and competitive position beyond COVID.
Hologic’s acquisition of Somatex Medical will expand its biopsy portfolio and direct channel in Germany.
Already cleared to monitor the viral load in HIV-positive individuals, the test has now been approved for initial diagnosis as well.
Device company M&A values reached $17.9bn in Q3, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $8.2bn.
- Contract Research Organization-CRO
- In Vitro Diagnostics
- Laboratory Testing Services
Diagnostic Imaging Equipment & Supplies
- Digital Imaging
- Diagnostic Imaging Equipment & Supplies
- Other Names / Subsidiaries
- Acessa Health Inc.
- Cytyc Corporation
- Faxitron Bioptics, LLC
- Focal Therapeutics, Inc.
- Gen-Probe Inc.
- Interlace Medical Inc.
- Palomar Medical Techologies
- SuperSonic Imagine
- Third Wave Technologies
- SOMATEX Medical Technologies GmbH